行业多源确认
药企百亿美元AI投资或寻错优势
Pharma’s Billion-Dollar AI Bets May Be Chasing the Wrong Advantage
精选理由
看看制药巨头们如何豪掷百亿美元投资AI，以及这些投入是否真的能带来竞争优势。
2026年成为制药业全面投入AI的关键一年。GSK与Noetik签署五年基础模型协议，Eli Lilly与NVIDIA共建联合创新实验室，Merck向谷歌云承诺投资十亿美元。多家药企竞相布局AI技术，但质疑这些巨额投资是否真正带来预期优势。
原文 · HIT Consultant
Pharma’s Billion-Dollar AI Bets May Be Chasing the Wrong Advantage
2026 will be remembered as the year pharma went all in on AI. Since January, nearly every major pharmaceutical company has announced some version of the same thing. GSK signed a five-year foundation-model deal with Noetik. Eli Lilly built a co-innovation lab with NVIDIA. Merck committed a billion dollars to Google Cloud. This month, Novo ... Read More